Dec 19 2018
The advanced sweat sensor company, Eccrine Systems, Inc., has announced that Dr Jason Heikenfeld, Co-Founder and CSO, and also a renowned researcher at the University of Cincinnati (UC), has received a major patent, US10136831. The exclusive rights to the UC patent are held by Eccrine Systems, Inc.
The patented development covers the application of on-body sweat devices that have the ability to electronically correlate two or more measurements of an analyte with the time at which the analyte evolved in newly excreted sweat. With the application of the invention, sweat analyte data trends can now be correlated with chronological blood values or analogous physiological measurements. The invention was developed by Heikenfeld over four years ago and at a time when constant on-body measurement of sweat analytes was still at the nascent stage. Heikenfeld is a prominent scientific leader of the wearable sweat sensor space and has many of its most significant and prescient developments to his credit.
Eccrine Systems, Inc. applies Heikenfeld’s invention in order to time-correlate the data obtained from its sweat sensor devices, such as algorithms and data that will define the pharmacokinetic, or PK, profile of drugs excreted in locally activated sweat.
Non-invasive medication monitoring is a great example of the utility of Jason’s invention. You can’t devise an on-body device to derive a sweat pharmacokinetic curve, and then correlate that curve to a drug’s blood PK curve, without using this invention. This is a big deal given the estimated $500 billion annual healthcare cost of non-optimized medication therapy, a significant portion of which can result from individual PK differences that cause failed treatment outcomes.
Dr Gavi Begtrup, CEO, Eccrine Systems, Inc.